CAT-2003

DRUG3 trials

Sponsors

Catabasis Pharmaceuticals

Conditions

Chylomicronemia, FamilialDyslipidemiaDyslipidemiasHypercholesterolemiaHyperlipidemiasHyperlipoproteinemia Type IHypertriglyceridemiaLipid Metabolism Disorders

Phase 2

Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

CompletedNCT01912560

Catabasis PharmaceuticalsDyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

Start: 2013-07-31End: 2013-12-31Updated: 2016-07-28

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

CompletedNCT01968720

Catabasis PharmaceuticalsDyslipidemias, Hyperlipidemias, Hypertriglyceridemia +2

Start: 2013-10-31End: 2014-04-30Updated: 2015-08-14

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

CompletedNCT02098278

Catabasis PharmaceuticalsChylomicronemia, Familial, Hyperlipoproteinemia Type I, Hypertriglyceridemia +1

Start: 2014-03-31End: 2015-04-30Updated: 2016-07-21